Drug Trial Radar · NCT04871451
Extension Study of ABP-19000 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 in Cervical Dystonia
Last checked: Nov 20, 2026Latest source record: Aug 22, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
51
Actual
Start
Jul 27, 2021
Primary completion
Jul 24, 2023
Study completion Jul 24, 2023
Sponsor
- Lead sponsor
- AEON Biopharma, Inc.Industry
- Sponsor type
- Industry
- First posted
- May 4, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This Open-label Extension trial will evaluate the safety and efficacy of ABP-450 for the treatment of cervical dystonia in adults. The study will enroll 60 patients across approximately 42 sites in the United States from Phase 2 (ABP-19000) trial. Study subjects who had their initial dose of study drug in the Phase 2 trial, irrespective of treatment allocation, will be eligible to enroll in this OLE study.
Conditions
- Cervical Dystonia
Interventions
ABP-450Drug
ABP-450 (prabotulinumtoxinA) contains a 900kDA botulinum toxin type-A complex produced by the bacterium Clostridium botulinum.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Treatment-related Serious Adverse EventsTime frame: Up to 52 weeks
Locations
20 sites in 1 country. Site status is shown where the registry gives one.
Arizona Neuroscience Research
Phoenix, Arizona
Parkinson's and Movement Disorder Institute
Fountain Valley, California
Neuro Pain Medical Center
Fresno, California
Loma Linda University
Loma Linda, California
New England Institute for Neurology and Headache
Stamford, Connecticut
Infinity Clinical Research LLC
Hollywood, Florida
Brainstorm Research
Miami, Florida
University of South Florida
Tampa, Florida
Neurology One
Winter Park, Florida
Emory University
Atlanta, Georgia
Rush University Medical Center
Chicago, Illinois
Michigan State University
East Lansing, Michigan
Quest Research Institute - Hunt - PPDS
Farmington Hills, Michigan
University of New Mexico
Albuquerque, New Mexico
The Cleveland Clinic Foundation
Cleveland, Ohio
Cleveland Clinic Lou Ruvo Center for Brain Health
Cleveland, Ohio
The Orthopedic Foundation
New Albany, Ohio
Veracity Neuroscience LLC
Memphis, Tennessee
Vanderbilt University Medical Center
Nashville, Tennessee
Baylor College of Medicine
Houston, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.